Does Dr. ALDO RAFAEL YARIHUAMAN have financial conflicts of interest?

Dr. ALDO RAFAEL YARIHUAMAN (MD) has received a total of $133,246 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $133,246 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALDO RAFAEL YARIHUAMAN?

According to CMS Open Payments data, Dr. ALDO RAFAEL YARIHUAMAN received funding from ABBOTT LABORATORIES ($108,933), EDWARDS LIFESCIENCES CORPORATION ($15,861), and MEDTRONIC ($4,630).

Does Dr. ALDO RAFAEL YARIHUAMAN receive research grants or speaking fees?

Dr. ALDO RAFAEL YARIHUAMAN has received $133,246 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ALDO RAFAEL YARIHUAMAN

MDReal-Time Hydrated

Specialty: Thoracic Surgery (Cardiothoracic Vascular Surgery)

Practice Location: DALLAS, TX 75226

NPI Number: 1043462609

LIFETIME INDUSTRY VALUE

$133,246

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. RAFAEL YARIHUAMAN is a verified Thoracic Surgery (Cardiothoracic Vascular Surgery) practitioner based in DALLAS, TX.

Between 2021 and 2025, Dr. RAFAEL YARIHUAMAN had an overall industry promotional and research financial footprint of $133,246 as recorded in the federal CMS Open Payments database.

$133,246 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. RAFAEL YARIHUAMAN's primary funding source is ABBOTT LABORATORIES, which accounts for $108,933 (representing 81.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$108,933

81.8%

EDWARDS LIFESCIENCES CORPORATION

Rank 2

$15,861

11.9%

MEDTRONIC

Rank 3

$4,630

3.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.